Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDA for Seasonal Migrant Farmworkers in Ethiopia
NCT06516042Phase 3Active, not recruiting
- Sponsor
- PATH
- Start
- Aug 2024
- Primary completion
- Jan 2025
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine in Plasmodium falciparum malaria, sponsored by PATH. Started Aug 2024; status: active, not recruiting.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT06516042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06516042.